RX CompoundedRxMonitor

Entity monitoring profile

University Compounding Pharmacy Verification and Monitoring Profile

Federal 503B registration status for University Compounding Pharmacy, checked against the complete FDA register, with the open fields that remain.

Direct answer

University Compounding Pharmacy does not appear on FDA's registered outsourcing facility list, checked in full against all 96 registrations at this snapshot. That is a verified absence from the federal 503B register — not a deficiency. Compounders operating under section 503A are licensed by state boards of pharmacy and do not appear on any federal registration list.

Key findings

  • Federal 503B registration: Not on the federal 503B register.
  • No entry under this name appears on FDA's registered outsourcing facility list at this snapshot. That is a verified absence from the federal 503B register, not a deficiency: compounders operating under section 503A are licens
  • Registration means FDA received the required filing — it is not approval and not a CGMP finding.
  • No inspection outcome, Form 483, warning letter, recall or disciplinary record is verified for this entity.
  • Checked against the complete FDA register of 96 outsourcing facility registrations.
University Compounding Pharmacy — federal register check and verification state (11 fields open)
Entity name as publishedUniversity Compounding Pharmacy
Federal 503B registrationNo Public Evidence Found Not on the federal 503B register
Registered site(s) on FDA listNone under this name
Registry checked against96 registrations, FDA list, 2026-07-23
Operating modelSection 503A state-licensed pharmacy (inferred from absence of federal registration; state licence not yet verified)
State licence and numberVerification Pending
Nonresident licencesVerification Pending
FDA inspection historyVerification Pending
Form 483 observationsVerification Pending
Warning lettersVerification Pending
Most recent action statusVerification Pending
Recalls (current)Verification Pending
Recalls (historical)Verification Pending
State disciplinary recordsVerification Pending
AccreditationsVerification Pending
OwnershipVerification Pending
Evidence status No Public Evidence Found
Verified 2026-07-23
Reviewer CompoundedRxMonitor Regulatory Desk
Snapshot 2026-07-23
Methodology v1.0
Sources checked FDA register (96 registrations) + 10 framework sources
This record is not published to search engines. No facility-type classification has been established for this entity against FDA's published outsourcing facility records. This is a verification state, not a finding. It remains reachable for anyone who has the link, and it is excluded from the sitemap and marked noindex until the evidence threshold in the publication gate is met.
What this status does and does not mean. Absence from the register means this entity is not a federally registered outsourcing facility. That is normal and lawful: Compounders operating under section 503A can only distribute compounded drugs based on receipt of valid prescriptions for identified individual patients. Outsourcing facilities may or may not receive patient-specific prescriptions. FDA

Federal registration status

No entry under this name appears on FDA's registered outsourcing facility list at this snapshot. That is a verified absence from the federal 503B register, not a deficiency: compounders operating under section 503A are licensed by state boards and do not appear on any federal registration list.

Note: a separate registrant, University of Tennessee (Memphis, TN), appears on the federal list. It is a different entity and is not connected to this profile.

Registration and inspections are facility specific. Facilities under common ownership and control are inspected individually. Before purchasing, FDA advises determining that the specific facility in which the drugs are compounded is an outsourcing facility with a satisfactory inspection. FDA

No federal registration entry. No entry under the University Compounding Pharmacy name appears among the 96 registrations on FDA's list at this snapshot. FDA updates the list weekly, so this record carries its own check date.
Compounded GLP-1 regulatory position. Both the tirzepatide and semaglutide shortages are resolved and FDA has proposed excluding both from the 503B bulks list. The full verified timeline, with sources, is maintained on the alerts and enforcement hub.

What this means

  • The full federal register was checked and the result is stated with its date.
  • Absence is reported as absence from a named list, not as a finding.
  • The state board holds the licence record that would complete this profile.

What this does not mean

  • That this entity is compliant, safe, or non-compliant — none is asserted.
  • That federal registration constitutes approval or a CGMP finding.
  • That absence from this list indicates any problem — it does not.

What can and cannot be established about University Compounding Pharmacy today?

Verification of a compounding entity runs across two separate systems that do not talk to each other. The federal system covers outsourcing facilities only: registration, CGMP inspection, Form 483 observations, warning letters and recalls. The state system covers licensure, scope of permitted compounding, and discipline — and it is the only system that covers 503A pharmacies at all.

For University Compounding Pharmacy, the federal side is settled in the negative — it is not on the register — which means the entire evidentiary weight falls on state records that have not been captured here.

The two verification systems as they apply to University Compounding Pharmacy
QuestionSystem that answers itStatus for this entity
Is it federally registered as a 503B facility?FDA outsourcing facility registerNo Public Evidence Found
Is its state pharmacy licence current?State board of pharmacyVerification Pending
Is it permitted to compound sterile preparations?State board permit classVerification Pending
Has FDA inspected it, and what was found?FDA inspection recordsVerification Pending
Are there Form 483 observations?FDA inspection recordsVerification Pending
Is there an active warning letter?FDA warning letter databaseVerification Pending
Any current or historical recalls?FDA enforcement reportsVerification Pending
Any state disciplinary action?State board ordersVerification Pending

What a buyer should do with this record

This page settles one question and names the records that settle the rest. It is a starting point for verification, not a substitute for it.

If a programme names University Compounding Pharmacy as its dispensing pharmacy, do not read its absence from the federal register as a problem — 503A pharmacies never appear there. Go to the state board register, which is the system that actually covers it.

What remains open for University Compounding Pharmacy

With University Compounding Pharmacy absent from the federal register, the entire evidentiary weight falls on state records. The board of pharmacy in its resident state holds the licence, the scope of permitted compounding, and any disciplinary history.

To determine whether a registered outsourcing facility has been the subject of a state enforcement action, FDA directs the public to check with the State Board of Pharmacy for the state in which the facility is located. FDA

The method used for each field, and why none of it can be inferred, is set out on the methodology page. Sector-level context on the gap between registration and inspection is on the monitoring hub.

Limitations of this record.
  • Checked against FDA's register of 96 registrations on 2026-07-23; FDA updates the list weekly.
  • Self-reported registration information on FDA's list has not been verified by FDA.
  • State licensure, inspection outcomes and enforcement records have not been checked for this entity.
  • Sector statistics describe the 503B population, not this entity.
Sources checked for this entity — 5 sources
Right to respond. If University Compounding Pharmacy believes any record on this page is inaccurate, incomplete, or out of date, it may submit a response through the right-to-respond process. Responses are published alongside the record without edit to their substance, and any accepted correction is logged in the update history above with its date.
Where the detail lives. The six parties in a compounded prescription, and which register holds each, are set out on the provider–pharmacy relationships page. The eight items to establish before paying any programme are listed on the patient safety page.

Section hub: Pharmacy profiles · Methodology · Status definitions · Right to respond

Frequently asked questions

Is University Compounding Pharmacy a registered 503B outsourcing facility?

No. No entry under this name appears among the 96 registrations on FDA's list at this snapshot.

Does that absence indicate a problem with University Compounding Pharmacy?

No. Compounders operating under section 503A are licensed by state boards of pharmacy and never appear on any federal registration list. Absence is normal and lawful.

How would I check University Compounding Pharmacy's licence then?

Through the board of pharmacy in the state where it operates. State boards hold licensure and disciplinary records; FDA's register does not cover 503A pharmacies.

Is there anything specific to note about University Compounding Pharmacy?

Note: a separate registrant, University of Tennessee (Memphis, TN), appears on the federal list. It is a different entity and is not connected to this profile.

Can University Compounding Pharmacy still compound semaglutide or tirzepatide?

Both shortages are resolved and FDA proposed on 30 April 2026 to exclude both from the 503B bulks list, restricting bulk compounding by outsourcing facilities. Narrow patient-specific 503A compounding may remain available. This page assesses no entity's compliance.

Does this page allege anything about University Compounding Pharmacy?

No. It reports federal register status with its source and date, and lists what remains unverified. No violation, finding, or concern is asserted.

Sources

Update history

Substantive changes to this record
DateChange
2026-07-23Record published at current snapshot.

Dates change only for substantive updates. Entities may submit a correction or response through the right-to-respond process.